<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9E6E29A1-FFE3-487C-84F6-02CD1B6E313A"><gtr:id>9E6E29A1-FFE3-487C-84F6-02CD1B6E313A</gtr:id><gtr:name>National Institute for Biological Standards and Control (NIBSC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C027B696-415D-497D-BBC6-55FBB48F2071"><gtr:id>C027B696-415D-497D-BBC6-55FBB48F2071</gtr:id><gtr:name>InhiBox</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/52AF26DF-D9A2-4A76-881B-2C421B622C30"><gtr:id>52AF26DF-D9A2-4A76-881B-2C421B622C30</gtr:id><gtr:name>Heidelberg University Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EAF17943-4FDF-4E08-A8D2-281D7130987C"><gtr:id>EAF17943-4FDF-4E08-A8D2-281D7130987C</gtr:id><gtr:name>Birkbeck, University of London</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB"><gtr:id>7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB</gtr:id><gtr:name>University of Geneva</gtr:name><gtr:address><gtr:line1>University of Geneva</gtr:line1><gtr:line2>30 Quai Ernest-Ansemet</gtr:line2><gtr:postCode>CH-1211</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3E307C53-15A8-4B25-8F70-AD6F13D14C9E"><gtr:id>3E307C53-15A8-4B25-8F70-AD6F13D14C9E</gtr:id><gtr:name>Molecular Nature Ltd</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9E6E29A1-FFE3-487C-84F6-02CD1B6E313A"><gtr:id>9E6E29A1-FFE3-487C-84F6-02CD1B6E313A</gtr:id><gtr:name>National Institute for Biological Standards and Control (NIBSC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C027B696-415D-497D-BBC6-55FBB48F2071"><gtr:id>C027B696-415D-497D-BBC6-55FBB48F2071</gtr:id><gtr:name>InhiBox</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/52AF26DF-D9A2-4A76-881B-2C421B622C30"><gtr:id>52AF26DF-D9A2-4A76-881B-2C421B622C30</gtr:id><gtr:name>Heidelberg University Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EAF17943-4FDF-4E08-A8D2-281D7130987C"><gtr:id>EAF17943-4FDF-4E08-A8D2-281D7130987C</gtr:id><gtr:name>Birkbeck, University of London</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB"><gtr:id>7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB</gtr:id><gtr:name>University of Geneva</gtr:name><gtr:address><gtr:line1>University of Geneva</gtr:line1><gtr:line2>30 Quai Ernest-Ansemet</gtr:line2><gtr:postCode>CH-1211</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3E307C53-15A8-4B25-8F70-AD6F13D14C9E"><gtr:id>3E307C53-15A8-4B25-8F70-AD6F13D14C9E</gtr:id><gtr:name>Molecular Nature Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/22F37EF0-8314-490D-9777-91764A58CEF3"><gtr:id>22F37EF0-8314-490D-9777-91764A58CEF3</gtr:id><gtr:firstName>Michael John</gtr:firstName><gtr:surname>Blackman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117532063"><gtr:id>3B3CC546-514B-48C4-B639-0D0EED6745F1</gtr:id><gtr:title>Proteases in host cell invasion by the malaria parasite</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117532063</gtr:grantReference><gtr:abstractText>Each year, over 2 million people die as a result of infection with the malaria parasite. Development of an effective vaccine has proved difficult, and in many parts of the world there is widespread resistance to available antimalarial drugs. In an infected person, the malaria parasite grows within red blood cells. To do this, the invasive merozoite form of the parasite must exit from its host cell at regular intervals of about 48 hours then bind to the outside of a new red cell and invade it. Exit and invasion require the activity of a number of parasite enzymes, called proteases. Work in this laboratory aims to understand how these proteases work, and to devise compounds which prevent their action, thereby blocking the parasites life cycle and the progress of the disease. Our work is intended to aid the development of a new class of antimalarial drugs based on protease inhibitors that will combat and control this devastating disease.</gtr:abstractText><gtr:technicalSummary>Malaria is directly responsible for an estimated 2-3 million deaths per annum, imposing an immense economic burden on much of the developing world. There is no malaria vaccine, and resistance against mainstay antimalarial drugs is widespread, resulting in an increasing threat to travellers.||Malaria is caused by an obligate intracellular parasite, which invades and replicates within red blood cells. We are interested in the molecular mechanisms by which the invasive blood-stage form of the parasite, the merozoite, modifies, exits and enters its host red cell.||Blood stages of the most virulent species of the malaria parasite, Plasmodium falciparum, can be cultured in vitro, and our work uses classical biochemical approaches, transgenesis and microscopy to study invasion in this system. A major element of our work makes use of heterologous expression systems for structural and enzymological studies.||At or around invasion, several essential parasite proteins are dramatically restructured as a result of proteolytic activity. A subtilisin-like parasite protease called PfSUB1 plays a role in release of the parasite from its host cell. At invasion, several merozoite surface proteins known to play a key role in invasion are precisely cleaved by another parasite subtilisin-like protease called PfSUB2 and shed from the merozoite surface. Our investigations of these proteases are focused on determining their structure, their fine substrate specificity and their precise function in the parasite as well as the identification of selective low molecular weight inhibitors of the enzymes that have potential for development as antimalarial drugs. In addition we have found that members of a different family of serine proteases called rhomboids, first discovered in Drosophila, also play an important role in invasion. We are engaged in active collaborations with other groups interested in the role of serine proteases in host cell invasion by related Apicomplexan parasites, including the pathogen Toxoplasma gondii. Our research focuses on the physiological significance of these proteolytic processing events, and the structural and functional characterization of the enzymes involved in these and other important protease-mediated processes during invasion. A better understanding of these will help to lay the groundwork for development of new, much needed drugs or vaccines which target processes and molecules involved in this critical step in the parasites life cycle.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1991-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>8095494</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>InhiBox</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Inhibitors of a malarial protease</gtr:description><gtr:id>2713C06F-611C-4BF2-BD8C-6B6BB71D2788</gtr:id><gtr:impact>The collaboration allowed preliminary selection of compounds that inhibit a malarial protease. Acted as a pilot study to promote further collaboration in this area. This has directly led to the establishment of a firm collaboration in the form of an EU Marie Curie funded network called STARS (total budget approx 2.1 million Euro) which will enable continuationof this work on the malarial enzyme. A publication has recently emanated from this collaboration (Withers-Martinez, C., Suarez, C., Fulle, S., Kher, S., Penzo, M., Ebejerb, J.-P., Koussis, K., Hackett, F., Jirgensons, A., Finn, P., and Blackman, M.J. (2012). Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target. Int J Parasitol 42, 597-612. PMID: 22796182)</gtr:impact><gtr:outcomeId>0B9CBB643B0-1</gtr:outcomeId><gtr:partnerContribution>Purchase and provision of selected ('focused') compound libraries for screening as potential malarial protease inhibitors. Acted as a pilot study to promote further collaboration in this area.</gtr:partnerContribution><gtr:piContribution>This work was in many ways an extension of the above collaborations. Inhibox specialise in use of structural data to screen in silico for tight-binding small molecule inhibitors. Our team at NIMR provided a homology model of a malarial protease of interest (built in collaboration with the Division of Mathematical Biology at NIMR) and experimental substrate data.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Infectious and Tropical Diseases</gtr:department><gtr:description>Malarial PKG in egress</gtr:description><gtr:id>3FC73B0E-539B-476C-A570-2658B1570B2D</gtr:id><gtr:impact>A paper describing the first publication emanating from this collaboration (Collins CR, Hackett F, Strath M, Penzo M, Withers-Martinez C, Baker DA, Blackman MJ [2013] Malaria parasite cGMP-dependent protein kinase regulates blood stage merozoite secretory organelle discharge and egress. PLoS Pathog.9:e1003344. PMID: 23675297) was used as a springboard for a successful grant application to the Wellcome Trust's Senior Investigator Award Programme early in 2015.</gtr:impact><gtr:outcomeId>inqdNSsJvX9-1</gtr:outcomeId><gtr:partnerContribution>Our partners originally provided low molecular weight PKG inhibitors and expertise in their use for this work. This has now been expanded into a full-scale collaboration funded by a joint Wellcome Trust Senior Investigator award.</gtr:partnerContribution><gtr:piContribution>We have established the mechanism by which inhibitors of a malarial cyclic GMP-dependent protein kinase (PKG) prevent release (egress) of the malaria parasite from its host red blood cell. This work has now been extended into a detailed analysis of the role of cGMP-dependent signalling in egress.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Development of a conditional gene disruption system for malaria</gtr:description><gtr:id>B57E1546-186E-49C5-A0D6-6EDBE1BE76E3</gtr:id><gtr:impact>This has now resulted in two joint publications (Collins CR, Das S, Wong EH, Andenmatten N, Stallmach R, Hackett, F, Herman, JP, Mueller, S, Meissner, M and Blackman, MJ (2013) Robust inducible Cre recombinase activity in the human malaria parasite Plasmodium falciparum enables efficient gene deletion within a single asexual erythrocytic growth cycle. Mol Microbiol. 88:687-701. PMID: 23489321; and Pieperhoff MS, Pall GS, Jim&amp;eacute;nez-Ruiz E, Das S, Melatti C, Gow M, Wong EH, Heng J, M&amp;uuml;ller S, Blackman MJ*, Meissner M* (2015) Conditional U1 Gene Silencing in Toxoplasma gondii. PLoS One. 10:e0130356). Ongoing work may lead to further high-impact publications.</gtr:impact><gtr:outcomeId>545cbff38909e8.16759839-1</gtr:outcomeId><gtr:partnerContribution>Our partners showed that this system functions in the related parasitic pathogen Toxoplasma gondii, encouraging us to attempt its establishment in P. falciparum. They also provided reagents and genetic tools.</gtr:partnerContribution><gtr:piContribution>This involved the development of a Cre-based conditional gene disruption system for use in the human malaria parasite Plasmodium falciparum. My team adapted this approach to P. falciparum and demonstrated that it can be used for rapid robust regulation of gene expression. In further work, a system based on U1-mediated RNA destabilisation has been shown tobe functional in the related pathogen Toxoplasma gondii but not to function in Plasmodium falciparum. This suggests differences in RNA splicing mechanisms between these related organisms.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Technology (MRCT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRCT Centre for Therapeutics Discovery (CTD)</gtr:department><gtr:description>MRCT</gtr:description><gtr:id>C433A543-E605-4731-8B69-9B920E912832</gtr:id><gtr:impact>This work (along with the Molecular Nature collaboration) has led to substantial advances on our understanding of the function of the protease undeer examination, as well as how the malaria parasite regulates release from its host red blood cell. Relevant publications leading from this work are PubMed ID 18083098, 18503638 and 19214190</gtr:impact><gtr:outcomeId>828CADE8602-1</gtr:outcomeId><gtr:partnerContribution>Provision of expert help, chemistry advice and screening capacity for high throughput screens of compound libraries in search for a malaria protease inhibitor.</gtr:partnerContribution><gtr:piContribution>This valuable collaboration involved multiple screens, used robotic facilities and expertise available at MRCT, of compound libraries from a variety of sources. Our team contributed purified recombinant malarial enzyme (protease) and substrate for the screen, as well as expertise. The funding was used to support a postdoctoral worker in my group, as well as to fund synthetic chemistry performed at MRCT.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Biological Standards and Control (NIBSC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Human adaptation of a malaria pathogen</gtr:description><gtr:id>CE4B4BAA-D7D6-4071-A2AA-A173D9385639</gtr:id><gtr:impact>A publication describing the successful adaptation of the parasite to in vitro growth in human red cells has been published (Moon RW, Hall J, Rangkuti F, Ho YS, Almond N, Mitchell GH, Pain A, Holder AA, Blackman MJ [2013] Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes. Proc Natl Acad Sci U S A. 110:531-6. PMID: 23267069 ). This work has led to the culture adaptation of an important human pathogen, which will be immensly valuable for all future work in this area, including validation of drug targets and vaccine development.</gtr:impact><gtr:outcomeId>ccr55xwA7P4-1</gtr:outcomeId><gtr:partnerContribution>Our partners provided primate (cynomolgus macaque) red blood cells for the early stages of adaptation.</gtr:partnerContribution><gtr:piContribution>This collaboration was initiated in order to adapt a newly recognised human malaria pathogen, Plasmodium knowlesi, to growth in vitro in human red blood cells. Adaptation was performed my members of my group.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Molecular Nature Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Molecular Nature Ltd</gtr:description><gtr:id>928B962F-CB5E-4DF3-80B8-4AC5AE6436C4</gtr:id><gtr:impact>Lead compounds selected from the screen were used to determine the function of the maalria protease under examination. This led to a breakthrough in our understanding of how the malaria parasite is released from its host red blood cell. See PubMed ID 18083098.</gtr:impact><gtr:outcomeId>25ED6945A30-1</gtr:outcomeId><gtr:partnerContribution>Provision of large amounts of a natural compound previously found (in a screen in collaboration with MRC Technology) to be a potent inhibitor of a malarial protease.</gtr:partnerContribution><gtr:piContribution>Compounds provided by Molecular Nature were screened for activity against a malarial protease using an assay developed by my research team at NIMR.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Birkbeck, University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biological Sciences</gtr:department><gtr:description>Structural analysis of malaria parasite egress.</gtr:description><gtr:id>DD91687C-A33E-4A90-9F16-5DA084BE570B</gtr:id><gtr:impact>This work has resulted in a recent publication (Watermeyer JM, Hale VL, Hackett F, Clare DK, Cutts EE, Vakonakis I, Fleck RA, Blackman MJ, Saibil HR. A spiral scaffold underlies cytoadherent knobs in Plasmodium falciparum-infected erythrocytes. Blood. 2016 127:343-51. doi: 10.1182/blood-2015-10-674002). Further publications are under preparation.</gtr:impact><gtr:outcomeId>56d86198e197b5.58104966-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators have special expertise in electron microscopy (EM), and they use EM and related technologies (e.g. tomography) to examine the structural changes that take place in the parasitised cell during egress.</gtr:partnerContribution><gtr:piContribution>This project focuses on determining the changes to the malaria parasite-infected erythrocyte that take place prior to and during release (egress) of the parasite from its host cell. We provide stringently synchronised parasite material and advice on how to work with it.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Heidelberg University Hospital</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Infectious diseases, Virology</gtr:department><gtr:description>University of Heidelberg</gtr:description><gtr:id>17FCCDBF-5E5F-493F-A44A-AC32123F942C</gtr:id><gtr:impact>Two publications this year (Child et al and Woehlbier et al). Not multidisciplinary.</gtr:impact><gtr:outcomeId>bwqgkPqiDW5-1</gtr:outcomeId><gtr:partnerContribution>Basic research - collaborators provided expertise and reagents</gtr:partnerContribution><gtr:piContribution>Major contributions to the intellectual and research input.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Geneva</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>BioMalpar-funded studentship</gtr:description><gtr:id>EEED8BC5-4AEA-41F4-B6C8-A8FA9B592D4A</gtr:id><gtr:impact>This has resulted in an improved understanding of host cell invasion by the causative agent of toxoplasmosis, and important and potentially serious opportunistic infection. Publications directly arising from it have PubMed ID numbers 19901027, 18818666 and 17491595.</gtr:impact><gtr:outcomeId>3A5AA8E6367-1</gtr:outcomeId><gtr:partnerContribution>The partnership used funding obtained from an EU source (the BioMalPar Network of excellence). The student was hosted jointly at the University of Geneva and NIMR.</gtr:partnerContribution><gtr:piContribution>This work involved a study of cell surface receptors used by the pathogen Toxoplasma gondii to invade cells. The main work was performed by a PhD student funded jointly by my research group and that of a collaborator at the University of Geneva (Prof Dominique Soldati)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Malaria proteases as drug targets</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>940F7321-85FF-4E0A-92C9-82FA50DAA79C</gtr:id><gtr:impact>I have given numerous presentations at a range of international scientific conferences (with audiences ranging from less than 100 to greater than 500).

Press release on a Cell paper describing the identification of a protease involved in red cell egress by the malaria parasite</gtr:impact><gtr:outcomeId>C44F672BCF4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The impact of malaria</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2269E80C-A27B-4E39-BE75-94E56924F1E9</gtr:id><gtr:impact>Took part in a Michael Mosely documentary aired on nationwide BBC TV, called 'Infested' and dedicated to pathogenic parasites. The programme resulted in lots of interest in our work and that on parasitic diseases generally.

Wider dissemination of the results of our research on malaria.</gtr:impact><gtr:outcomeId>A60362B8B4D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/programmes/b03vrwj8</gtr:url><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>094752</gtr:fundingRef><gtr:id>3B3D49DD-6D6D-44BD-94A1-A209DD15709F</gtr:id><gtr:outcomeId>DaDQgGBVt64</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1100013</gtr:fundingRef><gtr:id>F7410976-0D20-4298-9F37-18A8734C5F29</gtr:id><gtr:outcomeId>sUL4Q2ZmycF</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>280000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU-funded Network of Excellence (BioMalPar)</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>A28702EE-FC1A-466A-A278-A2A230A15165</gtr:id><gtr:outcomeId>D4DE669E5280</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>177006</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant-2009 &amp;quot;Proteases in egress of the malaria parasite from its host cell&amp;quot;</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>086550/Z/08/Z</gtr:fundingRef><gtr:id>9782F40C-24AD-4304-8316-281860333B96</gtr:id><gtr:outcomeId>85A19F6B3A90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>111924</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU-funded Marie Curie ITN (MalParTraining)</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>D6ADFD83-DCC8-4DEA-A5F4-2807E2302877</gtr:id><gtr:outcomeId>56DA590DF130</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Award</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>British Society for Parasitology (BSP)</gtr:fundingOrg><gtr:id>E708BB1E-78A4-490B-9400-DE05EC1AAF75</gtr:id><gtr:outcomeId>XG6UfkQAEp30</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>184907</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU-funded Marie Curie ITN (STARS)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:fundingRef>PITN-GA-2009-238490</gtr:fundingRef><gtr:id>B11F5483-A342-4810-BD26-EADCC34FB876</gtr:id><gtr:outcomeId>c9ebTnQPcP20</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>61617</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EviMalAR PhD Fellowship</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>066FB26D-6F25-4CF0-9DA2-10B31E5B3DDA</gtr:id><gtr:outcomeId>p7AAy8TkMqX0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>102888</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU- Network of Excellence-NOE-(Evimalar)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>242095</gtr:fundingRef><gtr:id>517A2D38-F196-4D4B-9A17-AEB1E15EA041</gtr:id><gtr:outcomeId>Mk1fwALVekM0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>166000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRCT Development Gap Funding (Inhibitors of a malarial serine protease)</gtr:description><gtr:end>2007-01-02</gtr:end><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>61E1FDFB-860B-47DD-A00C-99183B46BC07</gtr:id><gtr:outcomeId>0C75A49539E0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust/NIH PhD Studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>103459/Z/14/Z</gtr:fundingRef><gtr:id>0AB0B3CD-1930-4470-B7BD-77454DCCA05A</gtr:id><gtr:outcomeId>56d8695e836a77.27338780</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20941</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Training Day-2007 (MalParTraining&amp;quot;)</gtr:description><gtr:end>2007-04-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>A82FFAF8-9376-4A7A-9E2D-D9FB8A04403E</gtr:id><gtr:outcomeId>8D2922A2B380</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Swiss National Science Fund Fellowship</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Swiss National Science Foundation</gtr:fundingOrg><gtr:id>CEFB4817-5063-40D6-B1F3-F645D614987B</gtr:id><gtr:outcomeId>H2gPXyrBCVE0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>159360</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7-SP1-Cooperation-2009 (&amp;quot;MALSIG&amp;quot;)</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>732C469D-FE20-44C0-95AA-5278513827F2</gtr:id><gtr:outcomeId>341970143840</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>807654</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU-Networks for Initial Training-(InterMalTraining)</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>PITN-GA-2008-215281</gtr:fundingRef><gtr:id>6CC8A44C-78F5-409A-8B7A-B23ED731DC54</gtr:id><gtr:outcomeId>jZxkVGtqTEk0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Development of an assay to screen for inhibitors of an essential malarial protease that is a potential drug target.</gtr:description><gtr:id>9306439D-6940-44F0-8530-91B8DE1A5924</gtr:id><gtr:impact>Identification of drug-like inhibitors tht may have potential for development as new antimalarial drugs.</gtr:impact><gtr:outcomeId>F3A1441BC99</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>PfSUB1 malarial protease</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2007</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have adapted the DiCre gene disruption system to the humana malarial parasite P. falciparum. This for the first time provides a robust means of conditionally disrupting essential genes in order to study their function. This will revolutionise the malaria research field.</gtr:description><gtr:id>70D3CA7D-89FB-43A6-B696-3E043FB9825A</gtr:id><gtr:impact>This system has already allowed the genetic study of a number of essential malarial genes, and will continue to generate a high degree of interest across the malaria research field because of its enormous potential for the discovery of gene function.</gtr:impact><gtr:outcomeId>545cc9bb349f24.55035425</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DiCre in the malaria parasite</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=23489321</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Plasmodium knowlesi is an emerging human pathogen in large parts of SE Asia, but until recently could only be maintained by growth in vivo in primates. We have adapted a line of P. knowlesi to long-term continuous growth in vitro in human red blood cells, providing a new tool for researchers interested in this zoonotic pathogen.</gtr:description><gtr:id>21CDB819-B92A-4D3E-8602-DA979FD9754F</gtr:id><gtr:impact>This has enabled in-depth genomic and genetic studies on this important human pathogen, as well as a range of biological studies that have yet to reveal their full impact.</gtr:impact><gtr:outcomeId>545cc9009e6636.09727808</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human-adapted Plasmodium knowlesi</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/23267069</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Monoclonal antibodies (4 in total) specific for a malarial processing protease called PfSUB1.</gtr:description><gtr:id>C7149FD4-11B6-4222-9029-DB492E6E4469</gtr:id><gtr:impact>These have been used to follow the trafficking, subcellular sites of storage, and secretion of the protease, as well as to produce Fab fragments that have been used to solve the x-ray crystal structure of the enzyme. Initial data were recently published (Collins CR, Hackett F, Strath M, Penzo M, Withers-Martinez C, Baker DA, Blackman 
MJ [2013] Malaria parasite cGMP-dependent protein kinase regulates blood stage merozoite secretory organelle discharge and egress. PLoS Pathog. 9:e1003344).</gtr:impact><gtr:outcomeId>Bxita7zd536</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Anti-PfSUB1 mAbs</gtr:title><gtr:type>Antibody</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/24785947</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of a high throughput screen to search for inhibitors of an important malarial protease involved in host cell egress. Development of this took around 3 years of work and involved both intramural and industrial collaborations.</gtr:description><gtr:id>22B34112-CC2A-474C-98E8-AE3B00FB2F98</gtr:id><gtr:impact>It has been used to identify physiological substrates and the function of an important malarial enzyme and drug target</gtr:impact><gtr:outcomeId>572A64AA368</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PfSUB1 inhibitor screen</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A73FDBD6-735F-4135-B7DC-1D52C2E7C12D</gtr:id><gtr:title>Conditional U1 Gene Silencing in Toxoplasma gondii.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a52b5784f175cc90785501b37fdbd12"><gtr:id>6a52b5784f175cc90785501b37fdbd12</gtr:id><gtr:otherNames>Pieperhoff MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d6e9647b62a4.72781713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89080F97-5DC8-400F-B4EF-114901A7F6B5</gtr:id><gtr:title>Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c85feaade17df3c06262fa248da86937"><gtr:id>c85feaade17df3c06262fa248da86937</gtr:id><gtr:otherNames>Yeoh S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>15BD73BF78B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE7431BD-2FF6-4482-8F16-A9A0FD1F3565</gtr:id><gtr:title>Fragment-Based Discovery of 2-Aminoquinazolin-4(3H)-ones As Novel Class Nonpeptidomimetic Inhibitors of the Plasmepsins I, II, and IV.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ca0a8665961fa8b73afb2f683b0d7e2"><gtr:id>9ca0a8665961fa8b73afb2f683b0d7e2</gtr:id><gtr:otherNames>Rasina D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>56d6e963de4ac2.72496612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F694169B-291F-492D-93FA-B3A727BBB176</gtr:id><gtr:title>Intramembrane cleavage of AMA1 triggers Toxoplasma to switch from an invasive to a replicative mode.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27f16ded4720fed4b1e9c51e591f98b3"><gtr:id>27f16ded4720fed4b1e9c51e591f98b3</gtr:id><gtr:otherNames>Santos JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>qPaeyFLTury</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D12B5C67-406D-4E9C-8662-8C9AEAA27310</gtr:id><gtr:title>Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5211771b9988c81aea61d371b9ad55e4"><gtr:id>5211771b9988c81aea61d371b9ad55e4</gtr:id><gtr:otherNames>McConville M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>56d6e963610b59.56699930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F81B406-F2C6-437E-AF54-48EA7994DBAD</gtr:id><gtr:title>Extracellular ATP triggers proteolysis and cytosolic Ca&amp;sup2;? rise in Plasmodium berghei and Plasmodium yoelii malaria parasites.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f83164983f1673dcc46effd63da5db90"><gtr:id>f83164983f1673dcc46effd63da5db90</gtr:id><gtr:otherNames>Cruz LN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>pm_13468_28_22420332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B291ADE-FC41-46CF-B533-4327BC6BF6B0</gtr:id><gtr:title>Robust inducible Cre recombinase activity in the human malaria parasite Plasmodium falciparum enables efficient gene deletion within a single asexual erythrocytic growth cycle.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0fe083004e64b1ae619da28337777e2"><gtr:id>d0fe083004e64b1ae619da28337777e2</gtr:id><gtr:otherNames>Collins CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>pm_13468_28_23489321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB6DB27A-4E13-4034-8780-76052900B464</gtr:id><gtr:title>Roles of proteases during invasion and egress by Plasmodium and Toxoplasma.</gtr:title><gtr:parentPublicationTitle>Sub-cellular biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ec7113c29f76dd5ff188041c6264e99"><gtr:id>7ec7113c29f76dd5ff188041c6264e99</gtr:id><gtr:otherNames>Dowse TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0306-0225</gtr:issn><gtr:outcomeId>A4688B9984A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3AD0E73-703A-467B-88AB-EAD6D7C11608</gtr:id><gtr:title>Malarial proteases and host cell egress: an 'emerging' cascade.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c412da701630934ddb7906c312e3878"><gtr:id>4c412da701630934ddb7906c312e3878</gtr:id><gtr:otherNames>Blackman MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn><gtr:outcomeId>1EA8D1EB333</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF883270-B742-4E1A-91BB-EDC2C3C28273</gtr:id><gtr:title>Unique insertions within Plasmodium falciparum subtilisin-like protease-1 are crucial for enzyme maturation and activity.</gtr:title><gtr:parentPublicationTitle>Molecular and biochemical parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a54c90e23f0664178c7326e1d262414"><gtr:id>9a54c90e23f0664178c7326e1d262414</gtr:id><gtr:otherNames>Jean L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0166-6851</gtr:issn><gtr:outcomeId>0BF9E248160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B883F62-5485-4E08-9D93-D76394F7A272</gtr:id><gtr:title>Molecular identification of a malaria merozoite surface sheddase.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fc1383eaa3c18ad3749f674da470126"><gtr:id>2fc1383eaa3c18ad3749f674da470126</gtr:id><gtr:otherNames>Harris PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>8896A0A6D03</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19BEF220-2195-4551-94AC-CA6940534C0D</gtr:id><gtr:title>Processing of Plasmodium falciparum Merozoite Surface Protein MSP1 Activates a Spectrin-Binding Function Enabling Parasite Egress from RBCs.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a504a56bb9fa233e44d7ee8566f2030"><gtr:id>4a504a56bb9fa233e44d7ee8566f2030</gtr:id><gtr:otherNames>Das S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>56d6e963892fe0.18476612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB77B952-4052-4059-AA91-359481B66098</gtr:id><gtr:title>Regulated maturation of malaria merozoite surface protein-1 is essential for parasite growth.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad5d5b5bcdd02e5520a17476b5643e50"><gtr:id>ad5d5b5bcdd02e5520a17476b5643e50</gtr:id><gtr:otherNames>Child MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>hTkphameWb4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>788AD97A-C0D5-4CA7-8BD8-947A250B8466</gtr:id><gtr:title>Recent insights into apicomplexan parasite egress provide new views to a kill.</gtr:title><gtr:parentPublicationTitle>Current opinion in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c412da701630934ddb7906c312e3878"><gtr:id>4c412da701630934ddb7906c312e3878</gtr:id><gtr:otherNames>Blackman MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1369-5274</gtr:issn><gtr:outcomeId>pm_13468_28_23725669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C6106FC-D953-4E9A-9648-4C2B19606509</gtr:id><gtr:title>A perforin-like protein mediates disruption of the erythrocyte membrane during egress of Plasmodium berghei male gametocytes.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22defa9c31dc081cfb4e9277421f1d35"><gtr:id>22defa9c31dc081cfb4e9277421f1d35</gtr:id><gtr:otherNames>Deligianni E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn><gtr:outcomeId>pm_13468_28_23461714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>684558A4-45EC-418B-9B29-84057503C702</gtr:id><gtr:title>A plant-like kinase in Plasmodium falciparum regulates parasite egress from erythrocytes.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59cf48466113fc04c13708f8de961333"><gtr:id>59cf48466113fc04c13708f8de961333</gtr:id><gtr:otherNames>Dvorin JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>ejp2kzetybY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70DE23F8-E88C-4A9A-BCB6-ED7A68BFEE05</gtr:id><gtr:title>A role for poly(dA)poly(dT) tracts in directing activity of the Plasmodium falciparum calmodulin gene promoter.</gtr:title><gtr:parentPublicationTitle>Molecular and biochemical parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12ff93f1a6c439d21eaf6b20b8aa540d"><gtr:id>12ff93f1a6c439d21eaf6b20b8aa540d</gtr:id><gtr:otherNames>Polson HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0166-6851</gtr:issn><gtr:outcomeId>9E763D56A3A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAD1951D-DD45-416A-89DE-4634EB79AC73</gtr:id><gtr:title>Molecular determinants for subcellular trafficking of the malarial sheddase PfSUB2.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad5d5b5bcdd02e5520a17476b5643e50"><gtr:id>ad5d5b5bcdd02e5520a17476b5643e50</gtr:id><gtr:otherNames>Child MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>pm_13468_28_23834729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>819DDB0F-1ADD-4FC5-B966-D3F476FE776E</gtr:id><gtr:title>A new release on life: emerging concepts in proteolysis and parasite invasion.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4f1228df2b5c30ec692826c547fce6f"><gtr:id>b4f1228df2b5c30ec692826c547fce6f</gtr:id><gtr:otherNames>Carruthers VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>A7F250BE177</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46CFDA9A-B47B-4B19-A007-AE459906BC0B</gtr:id><gtr:title>Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin II.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31a9cba2f73768d0a5c4b0d5f482e13c"><gtr:id>31a9cba2f73768d0a5c4b0d5f482e13c</gtr:id><gtr:otherNames>Johansson PO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>5119F0EAAF5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>746920FC-E312-4AFE-9EE3-04B792AC75C3</gtr:id><gtr:title>A versatile strategy for rapid conditional genome engineering using loxP sites in a small synthetic intron in Plasmodium falciparum.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8dc0bc40087256064748df0bc908475e"><gtr:id>8dc0bc40087256064748df0bc908475e</gtr:id><gtr:otherNames>Jones ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56d6e964461821.38678081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>952E6051-B92C-4B54-956D-EE52C3A49651</gtr:id><gtr:title>Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.</gtr:title><gtr:parentPublicationTitle>International journal for parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80d7d930617b9d454e2c0a9dc77873be"><gtr:id>80d7d930617b9d454e2c0a9dc77873be</gtr:id><gtr:otherNames>Withers-Martinez C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0020-7519</gtr:issn><gtr:outcomeId>pm_13468_28_22543039</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63CFBE9F-F5C7-4C6D-99CF-6062097588EC</gtr:id><gtr:title>A multifunctional serine protease primes the malaria parasite for red blood cell invasion.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87064cc37406df2cfb7cc8c7f52709b4"><gtr:id>87064cc37406df2cfb7cc8c7f52709b4</gtr:id><gtr:otherNames>Koussis K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>B2E534E63D7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF4BE1F6-EE0D-44AF-B440-9091E8882C08</gtr:id><gtr:title>Proteolytic activation of the essential parasitophorous vacuole cysteine protease SERA6 accompanies malaria parasite egress from its host erythrocyte.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d36464595188fb3b03419b7352c84f4"><gtr:id>1d36464595188fb3b03419b7352c84f4</gtr:id><gtr:otherNames>Ruecker A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_13468_28_22984267</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6410E60-C389-44FE-810A-A83393E042B6</gtr:id><gtr:title>In silico study of subtilisin-like protease 1 (SUB1) from different Plasmodium species in complex with peptidyl-difluorostatones and characterization of potent pan-SUB1 inhibitors.</gtr:title><gtr:parentPublicationTitle>Journal of molecular graphics &amp; modelling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9246ade8fae13af7eb0274eb3f265daa"><gtr:id>9246ade8fae13af7eb0274eb3f265daa</gtr:id><gtr:otherNames>Brogi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1093-3263</gtr:issn><gtr:outcomeId>56d6e96418f992.78680512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BFA9566-163C-4FE3-AF24-AA802ACB3EF6</gtr:id><gtr:title>Structural insights into microneme protein assembly reveal a new mode of EGF domain recognition.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58b127d8637493f9b841c7fb9f17033c"><gtr:id>58b127d8637493f9b841c7fb9f17033c</gtr:id><gtr:otherNames>Sawmynaden K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>03BE0C72B83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7B4E2F3-63F4-4EE8-9D80-FA16AB59F39A</gtr:id><gtr:title>Malarial EBA-175 region VI crystallographic structure reveals a KIX-like binding interface.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80d7d930617b9d454e2c0a9dc77873be"><gtr:id>80d7d930617b9d454e2c0a9dc77873be</gtr:id><gtr:otherNames>Withers-Martinez C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>F0F9714E15D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97D8472A-C1DF-480B-8B46-B2F442D069A5</gtr:id><gtr:title>Juxtamembrane shedding of Plasmodium falciparum AMA1 is sequence independent and essential, and helps evade invasion-inhibitory antibodies.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b75ba864b7056c7b1957b679521097a"><gtr:id>6b75ba864b7056c7b1957b679521097a</gtr:id><gtr:otherNames>Olivieri A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>mSagsxGju3V</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06A7B07E-2D6E-49C0-A8A9-FE41B23CDBF8</gtr:id><gtr:title>Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4185ef77fa66941e37ef9e3a31304ec1"><gtr:id>4185ef77fa66941e37ef9e3a31304ec1</gtr:id><gtr:otherNames>Ersmark K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>E06AAE2E40F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1C8314C-BC80-4132-B5CC-C680638F90DE</gtr:id><gtr:title>Crystal structure of the malaria vaccine candidate apical membrane antigen 1.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62f54283d8b4ba83653f55f01fb0ffb5"><gtr:id>62f54283d8b4ba83653f55f01fb0ffb5</gtr:id><gtr:otherNames>Pizarro JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>8C8AE7C1431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F914D958-FFFC-4EC6-8896-99C1437154F9</gtr:id><gtr:title>Signalling in malaria parasites. The MALSIG consortium.</gtr:title><gtr:parentPublicationTitle>Parasite (Paris, France)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/540040d1c1228e9d773fee073af0bb60"><gtr:id>540040d1c1228e9d773fee073af0bb60</gtr:id><gtr:otherNames>Doerig C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1252-607X</gtr:issn><gtr:outcomeId>BB2E1EDA406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF18C670-EB53-45A7-B49F-E149E32DF302</gtr:id><gtr:title>Structural comparison of apical membrane antigen 1 orthologues and paralogues in apicomplexan parasites.</gtr:title><gtr:parentPublicationTitle>Molecular and biochemical parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d56317742244801fa30d6916b99a923"><gtr:id>5d56317742244801fa30d6916b99a923</gtr:id><gtr:otherNames>Chesne-Seck ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0166-6851</gtr:issn><gtr:outcomeId>CBB006E8077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3B55718-A98B-4FDD-B5BE-165C5037B2D9</gtr:id><gtr:title>Members of a novel protein family containing microneme adhesive repeat domains act as sialic acid-binding lectins during host cell invasion by apicomplexan parasites.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8d4ca9f379d0062514dc3803b71d747"><gtr:id>c8d4ca9f379d0062514dc3803b71d747</gtr:id><gtr:otherNames>Friedrich N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>44236638433</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3600B3BA-7D6A-4797-B941-34BB913D94D0</gtr:id><gtr:title>Global identification of multiple substrates for Plasmodium falciparum SUB1, an essential malarial processing protease.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/663b03075d9cb0bdb8627464745ead94"><gtr:id>663b03075d9cb0bdb8627464745ead94</gtr:id><gtr:otherNames>Silmon de Monerri NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>8B58ACB4_08B58ACB4_0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A51830B-1BF4-41A2-BF86-272F0E99D343</gtr:id><gtr:title>Plasmodium falciparum SERA5 plays a non-enzymatic role in the malarial asexual blood-stage lifecycle.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30e987caa102d0cd52a4785911c2680b"><gtr:id>30e987caa102d0cd52a4785911c2680b</gtr:id><gtr:otherNames>Stallmach R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>56d6e963330090.42691392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6149FC5-6145-4637-88C5-E6EB1F197730</gtr:id><gtr:title>Cyclic Nucleotide (cAMP and cGMP) Assays and Capture ELISA for Quantitative Analysis ofBlood-stage Egress.</gtr:title><gtr:parentPublicationTitle>Bio-protocol</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3156c6242819a1b4dfd67a694b8be28"><gtr:id>d3156c6242819a1b4dfd67a694b8be28</gtr:id><gtr:otherNames>Hackett F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2331-8325</gtr:issn><gtr:outcomeId>5a326034a7a324.21274773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DB1920E-8ACC-4F5E-B681-BA23E911A62D</gtr:id><gtr:title>Atomic resolution insight into host cell recognition by Toxoplasma gondii.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cf4cff10ae23c7c26befe3c67c77b68"><gtr:id>8cf4cff10ae23c7c26befe3c67c77b68</gtr:id><gtr:otherNames>Blumenschein TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>3512A621DE2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31B31955-9235-4DDB-A8D7-7259D33CC4A1</gtr:id><gtr:title>A conserved subtilisin protease identified in Babesia divergens merozoites.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbc555147e1c2f06d437853cdebfa0cb"><gtr:id>cbc555147e1c2f06d437853cdebfa0cb</gtr:id><gtr:otherNames>Montero E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5874E2CDC0C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBA4E585-CD8B-424E-B58D-6E9D0052E921</gtr:id><gtr:title>A spiral scaffold underlies cytoadherent knobs in Plasmodium falciparum-infected erythrocytes.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfd845bd6201e08a41584725b8143939"><gtr:id>cfd845bd6201e08a41584725b8143939</gtr:id><gtr:otherNames>Watermeyer JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>56d6e963b10eb8.51440482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA9CC6FD-F9C7-46D8-A07B-09BD227ED289</gtr:id><gtr:title>Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c60456b576a66a9001b580ef447bb08c"><gtr:id>c60456b576a66a9001b580ef447bb08c</gtr:id><gtr:otherNames>Woehlbier U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>ik5VCZgwCC5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>641E8102-AC78-4D4C-B303-367135285A6C</gtr:id><gtr:title>Identification of a Plasmodium falciparum phospholipid transfer protein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d164876977c72c0a07cddaecb362d15"><gtr:id>8d164876977c72c0a07cddaecb362d15</gtr:id><gtr:otherNames>van Ooij C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_13468_28_24043620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D83D059D-A69F-44B9-BA72-5EF31917F5C2</gtr:id><gtr:title>Intramembrane proteolysis mediates shedding of a key adhesin during erythrocyte invasion by the malaria parasite.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd50c16a54edca7952f59b4ae54f9bb3"><gtr:id>bd50c16a54edca7952f59b4ae54f9bb3</gtr:id><gtr:otherNames>O'Donnell RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>99E94254A2B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E037221B-4842-4060-83B6-43FF5BE1EAD5</gtr:id><gtr:title>An inhibitory antibody blocks interactions between components of the malarial invasion machinery.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0fe083004e64b1ae619da28337777e2"><gtr:id>d0fe083004e64b1ae619da28337777e2</gtr:id><gtr:otherNames>Collins CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>115ED0B4128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C905C2AD-3CD0-4DBE-BA2B-E7841DF0CB7E</gtr:id><gtr:title>Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0fe083004e64b1ae619da28337777e2"><gtr:id>d0fe083004e64b1ae619da28337777e2</gtr:id><gtr:otherNames>Collins CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>95254720DCC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CC263D3-0135-4FF5-8CBD-A662801BAF35</gtr:id><gtr:title>Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67adaeef43be98182c8836b3b09810b6"><gtr:id>67adaeef43be98182c8836b3b09810b6</gtr:id><gtr:otherNames>Gemma S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-894X</gtr:issn><gtr:outcomeId>pm_13468_28_22796182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E23123AB-0F3E-4496-85FF-30D0560D2799</gtr:id><gtr:title>Role of CpSUB1, a subtilisin-like protease, in Cryptosporidium parvum infection in vitro.</gtr:title><gtr:parentPublicationTitle>Eukaryotic cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c18337b40cc4288dafd0bd4e163cf6c"><gtr:id>6c18337b40cc4288dafd0bd4e163cf6c</gtr:id><gtr:otherNames>Wanyiri JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1535-9786</gtr:issn><gtr:outcomeId>3BC5B8FC915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4957543-539C-40AD-9EFB-67ED35F14302</gtr:id><gtr:title>Antibiotic recognition by binuclear metallo-beta-lactamases revealed by X-ray crystallography.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79c6810bc24c5416cc1731b11428ae57"><gtr:id>79c6810bc24c5416cc1731b11428ae57</gtr:id><gtr:otherNames>Spencer J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>2288CC46F7F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>980583F2-40BC-4E80-BC42-5B985D7EAEE6</gtr:id><gtr:title>Inhibition of erythrocyte invasion and Plasmodium falciparum merozoite surface protein 1 processing by human immunoglobulin G1 (IgG1) and IgG3 antibodies.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c492a550d996afcbcf9ab08f192bf17"><gtr:id>8c492a550d996afcbcf9ab08f192bf17</gtr:id><gtr:otherNames>Lazarou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>E59C23D9463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>879EB5E1-F58D-4574-A91F-E31779C4ECBF</gtr:id><gtr:title>Distinct mechanisms govern proteolytic shedding of a key invasion protein in apicomplexan pathogens.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/483c986515e80b3ad3392dc3fb088916"><gtr:id>483c986515e80b3ad3392dc3fb088916</gtr:id><gtr:otherNames>Howell SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>F54E20A7164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A506CEF0-1FA2-4813-A233-0D7CD59CC15E</gtr:id><gtr:title>The role of malaria merozoite proteases in red blood cell invasion.</gtr:title><gtr:parentPublicationTitle>Current opinion in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd50c16a54edca7952f59b4ae54f9bb3"><gtr:id>bd50c16a54edca7952f59b4ae54f9bb3</gtr:id><gtr:otherNames>O'Donnell RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1369-5274</gtr:issn><gtr:outcomeId>3565E7711D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1326DF8B-0372-4405-BEE2-F89174D1404F</gtr:id><gtr:title>Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0ea75fd2a6728eb2a54d0682b67694c"><gtr:id>c0ea75fd2a6728eb2a54d0682b67694c</gtr:id><gtr:otherNames>Moon RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13468_28_23267069</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30464540-13D0-4B4E-AB68-37CA4F180863</gtr:id><gtr:title>Normocyte-binding protein required for human erythrocyte invasion by the zoonotic malaria parasite Plasmodium knowlesi.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0ea75fd2a6728eb2a54d0682b67694c"><gtr:id>c0ea75fd2a6728eb2a54d0682b67694c</gtr:id><gtr:otherNames>Moon RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58c6b03c3adef8.86852724</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>225FCD90-616A-4769-BBBF-B44C0E5F204F</gtr:id><gtr:title>Malaria parasite cGMP-dependent protein kinase regulates blood stage merozoite secretory organelle discharge and egress.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0fe083004e64b1ae619da28337777e2"><gtr:id>d0fe083004e64b1ae619da28337777e2</gtr:id><gtr:otherNames>Collins CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_13468_28_23675297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76BFB42C-F8B8-4972-AD3D-29BD89BD0B59</gtr:id><gtr:title>Molecular determinants of binding to the Plasmodium subtilisin-like protease 1.</gtr:title><gtr:parentPublicationTitle>Journal of chemical information and modeling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9822db368a77bd68a82ee3dd53b92a74"><gtr:id>9822db368a77bd68a82ee3dd53b92a74</gtr:id><gtr:otherNames>Fulle S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-9596</gtr:issn><gtr:outcomeId>pm_13468_28_23414065</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117532063</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>